4.41
price up icon5.76%   0.24
after-market アフターアワーズ: 4.50 0.09 +2.04%
loading

Artiva Biotherapeutics Inc (ARTV) 最新ニュース

pulisher
Jan 02, 2026

Genelux Corporation Announces Appointment of Jason Litten as Chief Medical Officer, Effective January 2, 2026 - marketscreener.com

Jan 02, 2026
pulisher
Dec 20, 2025

Will Artiva Biotherapeutics Inc. stock gain from lower inflationJuly 2025 Levels & Risk Controlled Swing Alerts - Улправда

Dec 20, 2025
pulisher
Dec 19, 2025

Artiva Biotherapeutics (ARTV): Evaluating Valuation After CEO’s Latest Insider Share Sale - Yahoo Finance

Dec 19, 2025
pulisher
Dec 19, 2025

Will Artiva Biotherapeutics Inc. stock deliver long term returnsMarket Risk Summary & Reliable Entry Point Alerts - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Artiva Biotherapeutics Reports Increased Losses Amid Ongoing Development - MSN

Dec 19, 2025
pulisher
Dec 19, 2025

Is Artiva Biotherapeutics Inc. stock undervalued vs historical averagesJuly 2025 PreEarnings & Technical Pattern Based Signals - DonanımHaber

Dec 19, 2025
pulisher
Dec 18, 2025

Artiva Biotherapeutics, Inc.(NasdaqGM: ARTV) dropped from NASDAQ Biotechnology Index - marketscreener.com

Dec 18, 2025
pulisher
Dec 18, 2025

CEO Moves: Can Artiva Biotherapeutics Inc. stock rebound after recent weakness2025 Big Picture & High Accuracy Swing Entry Alerts - Улправда

Dec 18, 2025
pulisher
Dec 18, 2025

Can Artiva Biotherapeutics Inc. stock rebound after recent weaknessJuly 2025 Drop Watch & High Accuracy Swing Entry Alerts - Улправда

Dec 18, 2025
pulisher
Dec 18, 2025

Resistance Check: Can Artiva Biotherapeutics Inc. stock rebound after recent weaknessDividend Hike & Free Safe Entry Trade Signal Reports - Улправда

Dec 18, 2025
pulisher
Dec 17, 2025

ARTV Stock Price and Chart — NASDAQ:ARTV - TradingView — Track All Markets

Dec 17, 2025
pulisher
Dec 17, 2025

Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Dec 17, 2025
pulisher
Dec 17, 2025

Artiva Biotherapeutics CEO sells $19,122 in stock By Investing.com - Investing.com Nigeria

Dec 17, 2025
pulisher
Dec 16, 2025

12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga

Dec 16, 2025
pulisher
Dec 16, 2025

Artiva Biotherapeutics (ARTV) Stock: Today’s News (Dec. 16, 2025), Why Shares Spiked, Analyst Forecasts, and What Investors Are Watching Next - ts2.tech

Dec 16, 2025
pulisher
Dec 15, 2025

Insider Sell: Fred Aslan Sells Shares of Artiva Biotherapeutics Inc (ARTV) - GuruFocus

Dec 15, 2025
pulisher
Dec 15, 2025

Insider Selling: Artiva Biotherapeutics (NASDAQ:ARTV) CEO Sells 3,187 Shares of Stock - MarketBeat

Dec 15, 2025
pulisher
Dec 15, 2025

Artiva Biotherapeutics CEO sells $19,122 in stock - Investing.com

Dec 15, 2025
pulisher
Dec 15, 2025

12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga

Dec 15, 2025
pulisher
Dec 15, 2025

12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga

Dec 15, 2025
pulisher
Dec 15, 2025

US Stocks Mixed; NY Manufacturing Activity Dips In December - Benzinga

Dec 15, 2025
pulisher
Dec 14, 2025

Wedbush Predicts Up to ~600% Jump for These 2 ‘Strong Buy’ Stocks - Yahoo Finance

Dec 14, 2025
pulisher
Dec 12, 2025

Artiva Biotherapeutics Executes RSU Exchange for Employees - TipRanks

Dec 12, 2025
pulisher
Dec 12, 2025

Artiva Biotherapeutics Advances with Promising NK Cell Therapy Study - MSN

Dec 12, 2025
pulisher
Dec 11, 2025

Artiva Biotherapeutics executes RSU exchange for employees - MSN

Dec 11, 2025
pulisher
Dec 09, 2025

Pre Market Movers: XCUR, VOR, MTVA Set The Path - RTTNews

Dec 09, 2025
pulisher
Dec 09, 2025

Analysts Are Bullish on Top Healthcare Stocks: CG Oncology, Inc. (CGON), Nurix Therapeutics (NRIX) - The Globe and Mail

Dec 09, 2025
pulisher
Dec 04, 2025

How Artiva Biotherapeutics Inc. stock trades before earningsPortfolio Growth Summary & Free Risk Controlled Daily Trade Plans - Newser

Dec 04, 2025
pulisher
Dec 02, 2025

Will Artiva Biotherapeutics Inc. stock outperform tech sector in 2025Trade Exit Report & Consistent Profit Trading Strategies - Newser

Dec 02, 2025
pulisher
Nov 27, 2025

Risk Hedge: Can Artiva Biotherapeutics Inc. stock rebound after recent weakness2025 Institutional Moves & Daily Growth Stock Tips - moha.gov.vn

Nov 27, 2025
pulisher
Nov 27, 2025

A new trading data show Allarity Therapeutics Inc (ALLR) is showing positive returns. - Setenews

Nov 27, 2025
pulisher
Nov 25, 2025

Analysts Set Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Target Price at $19.00 - Defense World

Nov 25, 2025
pulisher
Nov 24, 2025

Artiva Biotherapeutics (ARTV) Stock Analysis Report | Financials & Insights - Benzinga

Nov 24, 2025
pulisher
Nov 24, 2025

LNP | LancasterOnline Events3rd Cell Therapy for Autoimmune Disease Summit - LancasterOnline

Nov 24, 2025
pulisher
Nov 20, 2025

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

Nov 20, 2025
pulisher
Nov 20, 2025

Why Artiva Biotherapeutics Inc. stock is seen as undervalued2025 Risk Factors & Reliable Momentum Entry Alerts - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Will Artiva Biotherapeutics Inc. stock beat EPS estimatesJuly 2025 Chart Watch & Fast Entry High Yield Stock Tips - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

How resilient is Artiva Biotherapeutics Inc. stock in market downturnsWeekly Investment Report & Expert Curated Trade Ideas - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Artiva Biotherapeutics Inc. stock attractive for retirement portfoliosWeekly Market Report & Weekly Consistent Profit Watchlists - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Why Artiva Biotherapeutics Inc. stock could rally in 2025 - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Artiva Biotherapeutics Inc. stock daily chart insights2025 Historical Comparison & Expert Verified Stock Movement Alerts - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Is Artiva Biotherapeutics Inc. stock supported by strong cash flows2025 Investor Takeaways & Long-Term Growth Portfolio Plans - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

ARTV: Off-the-shelf NK cell therapy for autoimmune disease advances toward pivotal RA trial with strong safety and funding - TradingView

Nov 18, 2025
pulisher
Nov 18, 2025

Artiva Biotherapeutics (NASDAQ:ARTV) CEO Sells $21,547.50 in Stock - MarketBeat

Nov 18, 2025
pulisher
Nov 18, 2025

Relative strength of Artiva Biotherapeutics Inc. in sector analysisSwing Trade & Free Weekly Watchlist of Top Performers - newser.com

Nov 18, 2025
pulisher
Nov 17, 2025

Aslan Fred sells Artiva Biotherapeutics (ARTV) stock for $21,522 By Investing.com - Investing.com UK

Nov 17, 2025
pulisher
Nov 17, 2025

Aslan Fred sells Artiva Biotherapeutics (ARTV) stock for $21,522 - Investing.com India

Nov 17, 2025
$40.65
price up icon 2.52%
$33.10
price up icon 4.09%
$106.66
price up icon 4.78%
$98.09
price up icon 1.28%
biotechnology ONC
$320.35
price up icon 0.02%
$175.07
price down icon 0.07%
大文字化:     |  ボリューム (24 時間):